KDP

Investors Are Bailing Out of Keurig Dr Pepper (KDP). Here's Why.

Keurig Dr Pepper stock is trading -9.65% below its average target price of $35.65 after dropping -3.1% during today's evening session. Analysts are giving the large-cap Beverages company an average rating of buy and target prices ranging from $27.0 to $42.0 per share.

Keurig Dr Pepper's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.7%. The stock's short ratio is 1.93. The company's insiders own 31.78% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Another number to watch is the company's rate of institutional share ownership, which now stands at 65.9%. In conclusion, we believe there is positive market sentiment regarding Keurig Dr Pepper.

Institutions Invested in Keurig Dr Pepper

Date Reported Holder Percentage Shares Value
2023-09-30 Capital World Investors 7% 94,294,221 $3,037,216,772
2023-09-30 Vanguard Group Inc 6% 82,196,547 $2,647,550,703
2023-09-30 Blackrock Inc. 5% 76,183,864 $2,453,882,189
2023-09-30 FMR, LLC 4% 60,682,003 $1,954,567,261
2023-09-30 Capital International Investors 4% 55,330,352 $1,782,190,587
2023-09-30 Wellington Management Group, LLP 3% 42,458,054 $1,367,573,880
2023-09-30 State Street Corporation 3% 41,855,850 $1,348,176,890
2023-09-30 Geode Capital Management, LLC 1% 19,654,857 $633,082,925
2023-09-30 Neuberger Berman Group, LLC 1% 16,117,843 $519,155,708
2023-09-30 T. Rowe Price Investment Management, Inc. 1% 15,993,354 $515,145,917
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS